Physician Assistant · Hutchinson, KS
NPI
1649587593
Since 2010
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2101 N Waldron St
Hutchinson, KS, 67502
Phone (620) 669-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
3,471 services
Medicare patients, 2024
888
Average age 73
Drug cost, 2024
$1.9M
4,089 prescriptions
Company payments, 2025
$2,207
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew J Osenbaugh was code 99214 (office e&m - established), 1,414 times for 737 patients. In total Matthew J Osenbaugh billed 3,471 services in 45 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,414 | 737 | $72.43 | $102K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 596 | 412 | $10.14 | $6,046 |
| 36415 Venipuncture Blood Collection | Office | 304 | 200 | $8.63 | $2,622 |
| 85025 Blood Count | Office | 183 | 123 | $7.55 | $1,381 |
| 80053 Clinical Chemistry | Office | 148 | 98 | $10.24 | $1,516 |
| 99232 Hospital E&M - Subsequent | Facility | 134 | 70 | $47.13 | $6,315 |
| 99222 Hospital E&M - Initial | Facility | 128 | 118 | $76.44 | $9,785 |
| 85610 Clinical Chemistry | Office | 85 | 50 | $4.20 | $357 |
| 83550 Clinical Chemistry | Office | 80 | 56 | $8.41 | $673 |
| 83540 Clinical Chemistry | Office | 79 | 55 | $6.22 | $491 |
| 82105 Clinical Chemistry | Office | 78 | 51 | $16.43 | $1,282 |
| 80076 Clinical Chemistry | Office | 37 | 29 | $8.01 | $296 |
| 99213 Office E&M - Established | Office | 31 | 28 | $45.74 | $1,418 |
| 99204 Office E&M - New | Office | 28 | 28 | $83.70 | $2,343 |
| 91110 Standard X-ray | Office | 23 | 23 | $374.03 | $8,603 |
By year: 2022 $136K for 2,551 services; 2023 $144K for 2,665 services; 2024 $148K for 3,471 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 304 | 200 | $8.63 | $2,622 |
| 85025 Blood Count | 183 | 123 | $7.55 | $1,381 |
| 80053 Clinical Chemistry | 148 | 98 | $10.24 | $1,516 |
| 85610 Clinical Chemistry | 85 | 50 | $4.20 | $357 |
| 83550 Clinical Chemistry | 80 | 56 | $8.41 | $673 |
| 83540 Clinical Chemistry | 79 | 55 | $6.22 | $491 |
| 82105 Clinical Chemistry | 78 | 51 | $16.43 | $1,282 |
| 80076 Clinical Chemistry | 37 | 29 | $8.01 | $296 |
| 86038 Immunoassay | 13 | 13 | $11.85 | $154 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew J Osenbaugh prescribed most often to Medicare patients was Pantoprazole Sodium, with 702 prescriptions and refills. In total Matthew J Osenbaugh wrote 4,089 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 702 | 1,368 | 179 | $7,842 |
| Omeprazole Generic | 538 | 1,112 | 130 | $5,561 |
| Metoclopramide Hcl Generic | 304 | 377 | 82 | $1,753 |
| Dicyclomine Hcl Generic | 244 | 271 | 79 | $5,292 |
| Linzess Linaclotide | 216 | 253 | 43 | $129K |
| Colestipol Hcl Generic | 183 | 267 | 43 | $17K |
| Cholestyramine Cholestyramine (With Sugar) | 174 | 204 | 58 | $10K |
| Creon Lipase/Protease/Amylase | 149 | 169 | 31 | $389K |
| Dexlansoprazole Dr Dexlansoprazole | 129 | 155 | 19 | $25K |
| Famotidine Generic | 124 | 170 | 21 | $1,193 |
| Sucralfate Generic | 116 | 155 | 30 | $3,087 |
| Mesalamine Generic | 96 | 136 | 16 | $53K |
| Azathioprine Generic | 95 | 101 | Under 11 | $4,203 |
| Erythromycin Erythromycin Base | 88 | 90 | 19 | $16K |
| Motegrity Prucalopride Succinate | 82 | 86 | 14 | $45K |
Brand drugs: 755 claims; generic drugs: 3,334 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew J Osenbaugh $2,207 ($2,207 in general payments such as food, travel and fees) from 17 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $408.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 21 | $408 |
| Abbvie Inc. ABBV | 35 | $399 |
| Janssen Biotech, Inc. JNJ | 13 | $307 |
| Lilly USA, LLC LLY | 11 | $291 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $176 |
| Aimmune Therapeutics, Inc. | 5 | $116 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $92.6 |
| Madrigal Pharmaceuticals MDGL | 5 | $80.94 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $77.04 |
| Ardelyx, Inc. ARDX | 4 | $62.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.